Abstract
Background In order to manage the COVID-19 systemic inflammatory response, it is important to identify clinicopathological characteristics across multiple cohorts.
Methods Electronic patient records for 2 consecutive cohorts of patients admitted to two urban teaching hospitals with COVID-19 during two 7-week periods of the COVID-19 pandemic in Glasgow, U.K. (cohort 1: 17th March 2020 – 1st May 2020) and (cohort 2: 18th May 2020 – 6th July 2020) were examined for routine clinical, laboratory and clinical outcome data.
Results Compared with cohort 1, cohort 2 were older (p<0.001), more likely to be female (p<0.05) and have less independent living circumstances (p<0.001). More patients in cohort 2 were PCR positive, CXR negative (both p<0.001) and had low serum albumin concentrations (p<0.001). 30-day mortality was similar between both cohorts (23% and 22%). Over the 2 cohorts, age ≥70 (p<0.001), male gender (p<0.05), hypertension (p<0.01), heart failure (p<0.05), cognitive impairment (p<0.001), frailty (p<0.001), COPD (p<0.05), delirium (p<0.001), elevated perioperative Glasgow Prognostic Score (p≤0.001), elevated neutrophil-lymphocyte ratio (p<0.001), low haematocrit (p<0.01), elevated urea (p<0.001), creatinine (p<0.001), glucose (p<0.05) and lactate (p<0.01); and the 4C score were associated with 30-day mortality. When compared with the 4C score, greater frailty (OR 10.2, 95% C.I. 3.4 – 30.6, p<0.01) and low albumin (OR 5.6, 95% C.I. 2.0 – 15.6, p<0.01) were strongly independently associated with 30-day mortality.
Conclusion In addition to the 4C mortality score, frailty score and a low albumin were strongly independently associated with 30-day mortality in two consecutive cohorts of patients admitted to hospital with COVID-19.
Article summary
In two consecutive cohorts of patients with COVID-19 infection admitted to two urban teaching hospitals in Glasgow, UK, there were variations in a number of clinicopathological characteristics despite similar mortality (23 and 22%).
In these two cohorts, in a multivariate analysis that included the 4C mortality score, clinical frailty score >3, low serum albumin concentration (<35 g/L), high neutrophil-lymphocyte ratio (≥5), and abnormal serum sodium concentration (<133/>145 mmol/L) remained independently associated with 30-day mortality.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
clinicaltrials.gov: NCT04484545
Clinical Protocols
https://clinicaltrials.gov/ct2/show/NCT04484545
Funding Statement
No funding received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In line with NHS policy, the NHS Greater Glasgow and Clyde Caldicott guardian approved this study. The study protocol (GN20AE307) was approved by the North West England-Preston research ethics committee (20/NW/0336) and registered with clinicaltrials.gov (NCT04484545).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Abbreviations
- (SARS-CoV-2 infection)
- COVID-19
- (SIRS)
- systemic inflammatory response syndrome
- (ISARIC)
- International Severe Acute Respiratory and emerging Infections Consortium
- (WHO)
- World Health Organization
- (CCP-UK)
- Clinical Characterisation Protocol UK
- (4C mortality score)
- study (performed by the ISARIC Coronavirus Clinical Characterisation Consortium—ISARIC-4C)
- (NEWS)
- national early warning score
- (PCR)
- Polymerase chain reaction
- (poGPS)
- peri-operative Glasgow Prognostic Score
- (NLR)
- neutrophil lymphocyte ratio
- (CRP)
- serum C-reactive protein
- (GRI)
- Glasgow Royal Infirmary
- (QEUH)
- Queen Elizabeth University Hospital
- (ED)
- Emergency Department
- (AAU)
- Acute Assessment Unit
- (CXR)
- chest X-ray
- (BMI)
- Body mass index
- (CFS)
- Clinical Frailty Scale
- (AVPU scale)
- Alert (A), responding to verbal (V), painful (P) stimuli and unresponsive (U)
- (SIMD)
- Scottish Indices of Multiple Deprivation
- (χ2 test)
- Chi-squared test
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos